TENX

Conviction 61HealthcareScan · Thu, Jun 25, 2026

TENX$12.88-0.39%

ResistanceSupportVol 14

Vol MA14 1.18M

Mar 26Apr 14May 1May 19Jun 8Jun 25

TENAX THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.tenaxthera.com ↗

Price12.88

Change-0.39%

Gap-0.77%

Rel volume2.86×

Avg volume1.08M

Avg $ vol12.76M

SMA 2011.58

SMA 5012.33

SMA 20011.18

Price vs 50+4.49%

Price vs 200+15.17%

MA stackbullish

50/200 cross—

Supertrendup · 10.93

RSI (14)59

MACD hist0.30

MACD crossbull · 8d

Stoch %K / %D73 / 82

ADX (14)21

+DI / −DI28 / 15

RSI divergence—

MACD divergenceBullish

ATR %+6.31%

ADR %6.16%

52w high18.27

52w low5.74

From 52w high-29.50%

Above 52w low+124.39%

New 52w highNo

SqueezeOff

Bollinger width29.31%

%B0.88

Donchian pos73.06%

Donchian high13.85

Donchian low10.25

AVWAP (52w high)13.03

vs AVWAP high-1.19%

AVWAP (52w low)12.38

vs AVWAP low+4.04%

OBV trendUp

Chaikin MF (20)-0.05

Today vs 20d2.86×

Avg vol (14d)1.18M

Avg vol (20d)1.08M

Avg $ vol (20d)12.76M

Market cap341.64M

RS 3m (vs SPY)-14.52%

RS 6m (vs SPY)-9.03%

RS line new highNo

Trend template5/8

Technical rank75.6

1 week+8.51%

1 month+7.51%

3 months-8.00%

6 months+3.37%

1 year+124.78%

YTD+16.56%

P/E-6.50

P/B2.98

P/S—

P/FCF-9.54

EPS-1.34

Div yield—

ROE-45.86%

ROA-42.70%

Debt/Eq—

Current14.52

EV/EBITDA-3.95

Gross margin—

Net margin—

Rev growth—

EPS growth-198.82%

Price target35.80

Target upside177.95%

Analyst ratingBuy

Institutional81.75%

Ent. value222.84M

Revenue0

Net income-15.72M

Gross profit0

Free cash flow-35.8M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out26.53M

Employees16

ListedWed, Feb 1, 1995

Free float5.59M

Float %89.6%

Short interest792.04K

Days to cover1.8d

Short volume52.4%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.35 vs −$0.40

Last surprise+12.5% beat

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank75.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance12.56

Support10.60

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TENX

All disclosures →

No recent disclosed trades by Congress in TENX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TENX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
STAAB THOMAS R II Chief Financial Officer · Stock Option (right to buy) · 2026-05-11	Grant	450K	$0	2026-05-11	2026-05-13
STAAB THOMAS R II Chief Financial Officer · Common Stock · 2026-05-11	Grant	10K	$0	2026-05-11	2026-05-13

SEC filings

EDGAR filings in TENX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.